Vilmos Fülöp
Vilmos Fülöp has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Dean Rea
School of Life Sciences, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK
3 shared publications- Dean Rea
School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK
2 shared publications - Shabir Najmudin
Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom
2 shared publications - Adrian. J. Lloyd
University of Warwick
1 shared publication - Anna York
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
1 shared publication - Anne-Marie Lambeir
Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium
1 shared publication
Latest Publications
- Open Access
- 13 November 2022
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 163 (46) , 1823-1833
A decidualizáció klinikai vonatkozásai
A sikeres fogantatás és terhesség elengedhetetlen összetevője a decidualizáció, amely az endometrium szerkezeti és funkcionális átalakulását jelenti. A folyamat magában foglalja a méhnyálkahártya szerkezeti változásait, a spirális arteriolák átalakulását, az endometriumban fellelhető, illetve később oda vándorló leukocyták számbeli és funkcionális adaptációját és a decidualis stromasejtek funkcionális és morfológiai változásait. A decidualizáció részeként az embrionális eredetű trophoblastsejtek szabályozott inváziót hajtanak végre az anyai eredetű szövetben, létrehozva a méhlepényt. A folyamat sikeréhez hozzájárul a trophoblastsejtek különleges antigenitása, illetve az immunológiai értelemben vett graft (magzat) és host (anya) között hormonok, citokinek és több receptor-ligand kapcsolat révén létrejövő kommunikáció. E folyamatok zavarai több, a fogamzást, beágyazódást és sikeres terhességet fenyegető kórkép alapját képezik, úgymint ismétlődő vetélés, praeeclampsia, méhen belüli sorvadás vagy koraszülés. Ebben a dolgozatunkban áttekintjük az élettani decidualizáció anatómiai, immunológiai és molekuláris alapjait, hogy aztán kitérjünk a szülészeti klinikumban előforduló gyakori kórképekre, melyek hátterében részben vagy egészen a decidualizáció valamely zavara állhat. Orv Hetil. 2022; 163(46): 1823–1833.
- 13 November 2022
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 163 (46) , 1823-1833
Open AccessA decidualizáció klinikai vonatkozásai
A sikeres fogantatás és terhesség elengedhetetlen összetevője a decidualizáció, amely az endometrium szerkezeti és funkcionális átalakulását jelenti. A folyamat magában foglalja a méhnyálkahártya szerkezeti változásait, a spirális arteriolák átalakulását, az endometriumban fellelhető, illetve később oda vándorló leukocyták számbeli és funkcionális adaptációját és a decidualis stromasejtek funkcionális és morfológiai változásait. A decidualizáció részeként az embrionális eredetű trophoblastsejtek szabályozott inváziót hajtanak végre az anyai eredetű szövetben, létrehozva a méhlepényt. A folyamat sikeréhez hozzájárul a trophoblastsejtek különleges antigenitása, illetve az immunológiai értelemben vett graft (magzat) és host (anya) között hormonok, citokinek és több receptor-ligand kapcsolat révén létrejövő kommunikáció. E folyamatok zavarai több, a fogamzást, beágyazódást és sikeres terhességet fenyegető kórkép alapját képezik, úgymint ismétlődő vetélés, praeeclampsia, méhen belüli sorvadás vagy koraszülés. Ebben a dolgozatunkban áttekintjük az élettani decidualizáció anatómiai, immunológiai és molekuláris alapjait, hogy aztán kitérjünk a szülészeti klinikumban előforduló gyakori kórképekre, melyek hátterében részben vagy egészen a decidualizáció valamely zavara állhat. Orv Hetil. 2022; 163(46): 1823–1833.
- Open Access
Structure-based modelling and dynamics of MurM, a Streptococcus pneumoniae penicillin resistance determinant that functions at the cytoplasmic membrane interface
MurM is an aminoacyl-tRNA dependant ligase that aminoacylates the Lipid II peptidoglycan precursor, in the human pathogen Streptococcus pneumoniae . MurM is required for the generation of branched peptidoglycan precursors enabling indirect cross-links in the peptidoglycan and is found to be essential for penicillin resistance. In this study we have solved the X-ray crystal structure of Staphylococcus aureus FemX, an isofunctional homologue of MurM, and used this as a template to generate a homology model of MurM. Using this model, we perform molecular docking and molecular dynamics to examine the interaction of the protein with the phospholipid bilayer and the membrane embedded Lipid II substrate of MurM. Our model suggests that MurM is associated with the major membrane phospholipid cardiolipin, and we confirm this with experimental evidence that the activity of MurM is enhanced by this phospholipid and inhibited by its direct precursor phosphatidylglycerol. This suggests that the spatial association of pneumococcal membrane phospholipids and their impact on MurM activity may be a critical to the final architecture of the peptidoglycan and the expression of clinically relevant penicillin resistance in this pathogen.
Open AccessStructure-based modelling and dynamics of MurM, a Streptococcus pneumoniae penicillin resistance determinant that functions at the cytoplasmic membrane interface
MurM is an aminoacyl-tRNA dependant ligase that aminoacylates the Lipid II peptidoglycan precursor, in the human pathogen Streptococcus pneumoniae . MurM is required for the generation of branched peptidoglycan precursors enabling indirect cross-links in the peptidoglycan and is found to be essential for penicillin resistance. In this study we have solved the X-ray crystal structure of Staphylococcus aureus FemX, an isofunctional homologue of MurM, and used this as a template to generate a homology model of MurM. Using this model, we perform molecular docking and molecular dynamics to examine the interaction of the protein with the phospholipid bilayer and the membrane embedded Lipid II substrate of MurM. Our model suggests that MurM is associated with the major membrane phospholipid cardiolipin, and we confirm this with experimental evidence that the activity of MurM is enhanced by this phospholipid and inhibited by its direct precursor phosphatidylglycerol. This suggests that the spatial association of pneumococcal membrane phospholipids and their impact on MurM activity may be a critical to the final architecture of the peptidoglycan and the expression of clinically relevant penicillin resistance in this pathogen.
- Open Access
Structural basis for control of antibiotic production by bacterial hormones
Summary: Actinobacteria produce numerous antibiotics and other specialised metabolites with important applications in medicine and agriculture. Diffusible hormones frequently control the production of such metabolites by binding TetR family transcriptional repressors (TFTRs), but the molecular basis for this remains unclear. The production of methylenomycin antibiotics in Streptomyces coelicolor A3(2) is initiated by binding of 2-alkyl-4-hydroxymethylfuran-3-carboxylic acid (AHFCA) hormones to the TFTR MmfR. Here, we report the X-ray crystal structure of an MmfR-AHFCA complex, establishing the structural basis for hormone recognition. We also elucidate the mechanism for DNA release upon hormone binding by single particle cryo-electron microscopy of an MmfR-operator complex. Electrophoretic mobility shift assays with MmfR mutants and synthetic AHFCA analogues illuminate the role played by individual amino acid residues and hormone functional groups in ligand recognition and DNA release. These findings will facilitate the exploitation of Actinobacterial hormones and their associated TFTRs in synthetic biology and novel antibiotic discovery.
Open AccessStructural basis for control of antibiotic production by bacterial hormones
Summary: Actinobacteria produce numerous antibiotics and other specialised metabolites with important applications in medicine and agriculture. Diffusible hormones frequently control the production of such metabolites by binding TetR family transcriptional repressors (TFTRs), but the molecular basis for this remains unclear. The production of methylenomycin antibiotics in Streptomyces coelicolor A3(2) is initiated by binding of 2-alkyl-4-hydroxymethylfuran-3-carboxylic acid (AHFCA) hormones to the TFTR MmfR. Here, we report the X-ray crystal structure of an MmfR-AHFCA complex, establishing the structural basis for hormone recognition. We also elucidate the mechanism for DNA release upon hormone binding by single particle cryo-electron microscopy of an MmfR-operator complex. Electrophoretic mobility shift assays with MmfR mutants and synthetic AHFCA analogues illuminate the role played by individual amino acid residues and hormone functional groups in ligand recognition and DNA release. These findings will facilitate the exploitation of Actinobacterial hormones and their associated TFTRs in synthetic biology and novel antibiotic discovery.
- Open Access
- 1 October 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 139, 482-491
Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling
- 1 October 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 139, 482-491
Open AccessCrystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling
- Open Access
- 12 November 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e79349
Crystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes
Oligopeptidase B cleaves after basic amino acids in peptides up to 30 residues. As a virulence factor in bacteria and trypanosomatid pathogens that is absent in higher eukaryotes, this is a promising drug target. Here we present ligand-free open state and inhibitor-bound closed state crystal structures of oligopeptidase B from Trypanosoma brucei, the causative agent of African sleeping sickness. These (and related) structures show the importance of structural dynamics, governed by a fine enthalpic and entropic balance, in substrate size selectivity and catalysis. Peptides over 30 residues cannot fit the enzyme cavity, preventing the complete domain closure required for a key propeller Asp/Glu to fix the catalytic His and Arg in the catalytically competent conformation. This size exclusion mechanism protects larger peptides and proteins from degradation. Similar bacterial prolyl endopeptidase and archael acylaminoacyl peptidase structures demonstrate this mechanism is conserved among oligopeptidase family enzymes across all three domains of life.
- 12 November 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e79349
Open AccessCrystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes
Oligopeptidase B cleaves after basic amino acids in peptides up to 30 residues. As a virulence factor in bacteria and trypanosomatid pathogens that is absent in higher eukaryotes, this is a promising drug target. Here we present ligand-free open state and inhibitor-bound closed state crystal structures of oligopeptidase B from Trypanosoma brucei, the causative agent of African sleeping sickness. These (and related) structures show the importance of structural dynamics, governed by a fine enthalpic and entropic balance, in substrate size selectivity and catalysis. Peptides over 30 residues cannot fit the enzyme cavity, preventing the complete domain closure required for a key propeller Asp/Glu to fix the catalytic His and Arg in the catalytically competent conformation. This size exclusion mechanism protects larger peptides and proteins from degradation. Similar bacterial prolyl endopeptidase and archael acylaminoacyl peptidase structures demonstrate this mechanism is conserved among oligopeptidase family enzymes across all three domains of life.
- 28 August 2013
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 8 (10) , 2339-2344
Structure and Mechanism of Acetolactate Decarboxylase
Acetolactate decarboxylase catalyzes the conversion of both enantiomers of acetolactate to the (R)-enantiomer of acetoin, via a mechanism that has been shown to involve a prior rearrangement of the non-natural (R)-enantiomer substrate to the natural (S)-enantiomer. In this paper, a series of crystal structures of ALDC complex with designed transition state mimics are reported. These structures, coupled with inhibition studies and site-directed mutagenesis provide an improved understanding of the molecular processes involved in the stereoselective decarboxylation/protonation events. A mechanism for the transformation of each enantiomer of acetolactate is proposed.
- 28 August 2013
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 8 (10) , 2339-2344
Structure and Mechanism of Acetolactate Decarboxylase
Acetolactate decarboxylase catalyzes the conversion of both enantiomers of acetolactate to the (R)-enantiomer of acetoin, via a mechanism that has been shown to involve a prior rearrangement of the non-natural (R)-enantiomer substrate to the natural (S)-enantiomer. In this paper, a series of crystal structures of ALDC complex with designed transition state mimics are reported. These structures, coupled with inhibition studies and site-directed mutagenesis provide an improved understanding of the molecular processes involved in the stereoselective decarboxylation/protonation events. A mechanism for the transformation of each enantiomer of acetolactate is proposed.
- Open Access
- 1 July 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (13) , 4775-4782
Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide
- 1 July 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (13) , 4775-4782
Open AccessInhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide
- 25 January 2008
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 47 (7) , 1947-1956
Redox-Linked Structural Changes Associated with the Formation of a Catalytically Competent Form of the Diheme CytochromecPeroxidase fromPseudomonas aeruginosa,
A recombinant form of the prototypic diheme bacterial cytochrome c peroxidase (BCCP) from Pseudomonas aeruginosa (PsaCCP) has been expressed in Escherichia coli and purified to homogeneity. This material was used to carry out the first integrated biochemical, spectroscopic and structural investigation of the factors leading to reductive activation of this class of enzymes. A single, tightly bound, Ca2+ ion (K = 3 × 1010 M-1) found at the domain interface of both the fully oxidized and mixed-valence forms of the enzyme is absolutely required for catalytic activity. Reduction of the electron-transferring (high-potential) heme in the presence of Ca2+ ions triggers substantial structural rearrangements around the active-site (low-potential) heme to allow substrate binding and catalysis. The enzyme also forms a mixed-valence state in the absence of Ca2+ ions, but a combination of electronic absorption, and EPR spectroscopies suggests that under these circumstances the low potential heme remains six-coordinate, unable to bind substrate and therefore catalytically inactive. Our observations strongly suggest that the two mixed-valence forms of native PsaCCP reported previously by Foote and colleagues (Foote, N., Peterson, J., Gadsby, P., Greenwood, C., and Thomson, A. (1985) Biochem. J.230, 227−237) correspond to the Ca2+-loaded and -depleted forms of the enzyme.
- 25 January 2008
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 47 (7) , 1947-1956
Redox-Linked Structural Changes Associated with the Formation of a Catalytically Competent Form of the Diheme CytochromecPeroxidase fromPseudomonas aeruginosa,
A recombinant form of the prototypic diheme bacterial cytochrome c peroxidase (BCCP) from Pseudomonas aeruginosa (PsaCCP) has been expressed in Escherichia coli and purified to homogeneity. This material was used to carry out the first integrated biochemical, spectroscopic and structural investigation of the factors leading to reductive activation of this class of enzymes. A single, tightly bound, Ca2+ ion (K = 3 × 1010 M-1) found at the domain interface of both the fully oxidized and mixed-valence forms of the enzyme is absolutely required for catalytic activity. Reduction of the electron-transferring (high-potential) heme in the presence of Ca2+ ions triggers substantial structural rearrangements around the active-site (low-potential) heme to allow substrate binding and catalysis. The enzyme also forms a mixed-valence state in the absence of Ca2+ ions, but a combination of electronic absorption, and EPR spectroscopies suggests that under these circumstances the low potential heme remains six-coordinate, unable to bind substrate and therefore catalytically inactive. Our observations strongly suggest that the two mixed-valence forms of native PsaCCP reported previously by Foote and colleagues (Foote, N., Peterson, J., Gadsby, P., Greenwood, C., and Thomson, A. (1985) Biochem. J.230, 227−237) correspond to the Ca2+-loaded and -depleted forms of the enzyme.
- 23 May 2003
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 59 (6) , 1073-1075
Purification, crystallization and preliminary X-ray crystallographic studies on acetolactate decarboxylase
Acetolactate decarboxylase has the unique ability to decarboxylate both enantiomers of acetolactate to give a single enantiomer of the decarboxylation product, (R)-acetoin. A gene coding for alpha-acetolactate decarboxylase from Bacillus brevis (ATCC 11031) was cloned and overexpressed in B. subtilis. The enzyme was purified in two steps to homogeneity prior to crystallization. Three different diffraction-quality crystal forms were obtained by the hanging-drop vapour-diffusion method using a number of screening conditions. The best crystal form is suitable for structural studies and was grown from solutions containing 20% PEG 2000 MME, 10 mM cadmium chloride and 0.1 M Tris-HCl pH 7.0. They grew to a maximum dimension of approximately 0.4 mm and belong to the trigonal space group P3(1,2)21, with unit-cell parameters a = 47.0, c = 198.9 A. A complete data set was collected to 2 A from a single native crystal using synchrotron radiation.
- 23 May 2003
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 59 (6) , 1073-1075
Purification, crystallization and preliminary X-ray crystallographic studies on acetolactate decarboxylase
Acetolactate decarboxylase has the unique ability to decarboxylate both enantiomers of acetolactate to give a single enantiomer of the decarboxylation product, (R)-acetoin. A gene coding for alpha-acetolactate decarboxylase from Bacillus brevis (ATCC 11031) was cloned and overexpressed in B. subtilis. The enzyme was purified in two steps to homogeneity prior to crystallization. Three different diffraction-quality crystal forms were obtained by the hanging-drop vapour-diffusion method using a number of screening conditions. The best crystal form is suitable for structural studies and was grown from solutions containing 20% PEG 2000 MME, 10 mM cadmium chloride and 0.1 M Tris-HCl pH 7.0. They grew to a maximum dimension of approximately 0.4 mm and belong to the trigonal space group P3(1,2)21, with unit-cell parameters a = 47.0, c = 198.9 A. A complete data set was collected to 2 A from a single native crystal using synchrotron radiation.
- 6 February 1992
- Published by Oxford University Press (OUP)
- p. 20-28
High speed, high resolution data collection on spinach Rubisco using a Weissenberg camera at the Photon Factory
- 6 February 1992
- Published by Oxford University Press (OUP)
- p. 20-28
High speed, high resolution data collection on spinach Rubisco using a Weissenberg camera at the Photon Factory